wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26786524-0185F61A-488A-4866-A75F-CE2DCD0FF3E9
Q26786524-0185F61A-488A-4866-A75F-CE2DCD0FF3E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786524-0185F61A-488A-4866-A75F-CE2DCD0FF3E9
What's next after metformin? focus on sulphonylurea: add-on or combination therapy
P2860
Q26786524-0185F61A-488A-4866-A75F-CE2DCD0FF3E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786524-0185F61A-488A-4866-A75F-CE2DCD0FF3E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e27942ef66445a05fa72cc5c3b508ceabfc175e
P2860
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors